William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
-
William Blair Downgrades VistaGen Therapeutics (VTGN) to Market Perform
-
Coursera to buy Udemy, creating $2.5 billion firm to target AI training
-
William Blair: 'SharkNinja is our top pick heading into 2026'
-
Andersen Announces Pricing of Initial Public Offering
-
Medline Announces Pricing of Upsized Initial Public Offering
-
Rekor Systems closes $15 million stock offering
-
Rekor Systems Announces Closing of $15.0 Million Underwritten Registered Direct Offering
-
Better Being Announces Strategic Transaction to Power Next Phase of Growth
-
Form D William Blair MB Investm
-
MIAX completes secondary offering of 7.8 million shares at $41 each
-
Miami International Holdings Announces Closing of Secondary Public Offering of Common Stock
-
William Blair: 'We Have No Concerns About Arista’s Durable Growth Prospects'
-
Rekor Systems prices $15 million direct offering at $1.75 per unit
-
Rekor Systems Announces Pricing of $15.0 Million Underwritten Registered Direct Offering
-
William Blair Starts The RealReal Inc. (REAL) at Outperform
-
William Blair Reiterates Outperform Rating on Apellis Pharmaceuticals (APLS)
-
William Blair Reiterates Outperform Rating on Arm Holdings (ARM)
-
William Blair Starts Aardvark Therapeutics Inc (AARD) at Outperform
-
Contineum Therapeutics prices $90 million public offering at $12.25 per share
-
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
-
MIAX prices secondary offering of 6.75 million shares at $41 each
-
Miami International Holdings Announces Pricing of Secondary Public Offering of Common Stock
-
Form DEF 14A WILLIAM BLAIR FUNDS For: Jan 27
-
Contineum Therapeutics announces $75 million public offering
-
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
-
Presenting Companies and Schedule Announced for the 2026 ICR Conference
-
CenterOak Partners Announces Sale of Turf Masters Brands
-
William Blair Reiterates Outperform Rating on Oracle (ORCL)
-
Perimeter Solutions to acquire Medical Manufacturing Technologies for $685 million
-
Arcline to Sell Medical Manufacturing Technologies to Perimeter Solutions for $685 Million
-
Lumexa Imaging prices IPO at $18.50 per share
-
Lumexa Imaging Announces Pricing of Initial Public Offering
-
William Blair Reiterates Market Perform Rating on Palantir Technologies Inc. (PLTR)
-
GE Vernova hits record high on bullish 2026 revenue outlook, buyback boost
-
William Blair Starts Unisys (UIS) at Outperform
-
William Blair on GE Vernova (GEV): 'leader in energy and power infrastructure, in our view the most important component to the AI theme'
-
William Blair on AAON Inc (AAON): 'Stock Weak on No New Information – Great Buying Opportunity'
-
Raleigh construction firm Cardinal Infrastructure raises about $241.5 million in US IPO
-
Cardinal Infrastructure Group prices IPO at $21 per share
-
Cardinal Infrastructure Group Inc. Announces Pricing of Initial Public Offering
-
MIAX announces secondary offering of 6.75 million shares
-
Miami International Holdings Announces Launch of Secondary Public Offering of Common Stock
-
William Blair Downgrades Gogo (GOGO) to Market Perform
-
China likely to set limits on access to Nvidia’s H200 chip - FT
-
William Blair Starts Owlet Inc. (OWLT) at Outperform
-
United Flow Technologies Announces Strategic Investment From Berkshire Partners
-
William Blair Downgrades Confluent Inc (CFLT) to Market Perform
-
United Flow Technologies Announces Strategic Investment From Berkshire Partners
-
Andersen Announces Launch of Initial Public Offering

